-
1
-
-
0033670419
-
LQC-Studiengruppe. Lebensqualität und Compliance von Patienten beider spezifischen Immuntherapie mit Gräser- und Roggenallergenen(LQC- Studie)
-
K.C. Bergmann H. Wolf J. Schnitker 2000 LQC-Studiengruppe. Lebensqualität und Compliance von Patienten bei der spezifischenImmuntherapie mit Gräser- und Roggenallergenen (LQC-Studie) Allergo J 9 4808
-
(2000)
Allergo J
, vol.9
, pp. 480-8
-
-
Bergmann, K.C.1
Wolf, H.2
Schnitker, J.3
-
2
-
-
0015912563
-
Drug therapy: Patient compliance
-
B. Blackwell 1973 Drug therapy: patient compliance N Engl J Med 289 24952
-
(1973)
N Engl J Med
, vol.289
, pp. 249-52
-
-
Blackwell, B.1
-
3
-
-
0033547741
-
Effect of initial drug choice on persistence with antihypertensivetherapy: The importance of actual practice data
-
J.J. Caro J.L. Speckman M. Salas 1999 Effect of initial drug choice onpersistence with antihypertensive therapy: the importance of actual practicedata CMAJ 160 41 6
-
(1999)
CMAJ
, vol.160
, pp. 41-6
-
-
Caro, J.J.1
Speckman, J.L.2
Salas, M.3
-
4
-
-
0027520808
-
Determinants of patient compliance with allergen immunotherapy
-
J.R. Cohn A. Pizzi 1993 Determinants of patient compliance with allergenimmunotherapy J Allergy Clin Immunol 91 734 7
-
(1993)
J Allergy Clin Immunol
, vol.91
, pp. 734-7
-
-
Cohn, J.R.1
Pizzi, A.2
-
6
-
-
0343467525
-
Preventive allergy treatment (PAT) by use of specific immunotherapy (SIT)
-
L. Jacobsen S. Dreborg C. Moller 1995 Preventive allergy treatment (PAT)by use of specific immunotherapy (SIT) Allergy 50 50
-
(1995)
Allergy
, vol.50
, pp. 50
-
-
Jacobsen, L.1
Dreborg, S.2
Moller, C.3
-
7
-
-
33644616286
-
Die spezifische Immuntherapie bei IgE-vermittelten allergischenErkrankungen, Leitlinie der DGAKI, ÄDA und GPA
-
J. Klein-Tebbe K.-C. Bergmann F. Friedrichs 2006 Die spezifischeImmuntherapie bei IgE-vermittelten allergischen Erkrankungen, Leitlinie derDGAKI, ÄDA und GPA Allergo J 15 56 74
-
(2006)
Allergo J
, vol.15
, pp. 56-74
-
-
Klein-Tebbe, J.1
Bergmann, K.-C.2
Friedrichs, F.3
-
8
-
-
3042788106
-
Quantitative assessment of the adherence to sublingual immunotherapy
-
C. Lombardi F. Gani M. Landi 2004 Quantitative assessment of theadherence to sublingual immunotherapy J Allergy Clin Immunol 113 1219 20
-
(2004)
J Allergy Clin Immunol
, vol.113
, pp. 1219-20
-
-
Lombardi, C.1
Gani, F.2
Landi, M.3
-
9
-
-
0027310396
-
Compliance with allergen immunotherapy
-
T. Lower J. Henry L. Mandik 1993 Compliance with allergen immunotherapyAnn Allergy 70 480 2
-
(1993)
Ann Allergy
, vol.70
, pp. 480-2
-
-
Lower, T.1
Henry, J.2
Mandik, L.3
-
10
-
-
6344237121
-
Randomized controlled open study of sublingual immunotherapy forrespiratory allergy in real-life: Clinical efficacy and more
-
M. Marogna I. Spadolini A. Massolo 2004 Randomized controlled open studyof sublingual immunotherapy for respiratory allergy in real-life: clinicalefficacy and more Allergy 59 1205 10
-
(2004)
Allergy
, vol.59
, pp. 1205-10
-
-
Marogna, M.1
Spadolini, I.2
Massolo, A.3
-
11
-
-
0036122326
-
Factors affecting compliance with allergen immunotherapy at a militarymedical center
-
D.R. More L.L. Hagan 2002 Factors affecting compliance with allergenimmunotherapy at a military medical center Ann Allergy Asthma Immunol 88 391 4
-
(2002)
Ann Allergy Asthma Immunol
, vol.88
, pp. 391-4
-
-
More, D.R.1
Hagan, L.L.2
-
12
-
-
0029872473
-
Cholesterol-Reduction Intervention Study (CRIS): A randomized trial toassess effectiveness and costs in clinical practice
-
G. Oster G.M. Borok J. Menzin 1996 Cholesterol-Reduction InterventionStudy (CRIS): a randomized trial to assess effectiveness and costs in clinicalpractice Arch Intern Med 156 731 9
-
(1996)
Arch Intern Med
, vol.156
, pp. 731-9
-
-
Oster, G.1
Borok, G.M.2
Menzin, J.3
-
13
-
-
28444463609
-
Children's compliance with allergen immunotherapy according toadministration routes
-
G.B. Pajno D. Vita L. Caminiti 2005 Children's compliance with allergenimmunotherapy according to administration routes J Allergy Clin Immunol 116 13801
-
(2005)
J Allergy Clin Immunol
, vol.116
, pp. 1380-1
-
-
Pajno, G.B.1
Vita, D.2
Caminiti, L.3
-
14
-
-
0033034816
-
Patient dropouts before completion of optimal dose, multiple allergenimmunotherapy
-
B.J. Rhodes 1999 Patient dropouts before completion of optimal dose,multiple allergen immunotherapy Ann Allergy Asthma Immunol 82 281 6
-
(1999)
Ann Allergy Asthma Immunol
, vol.82
, pp. 281-6
-
-
Rhodes, B.J.1
-
16
-
-
0001893910
-
Patienten-Compliance bei der Hyposensibilisierung
-
J. Sennekamp S. Walter 1998 Patienten-Compliance bei derHyposensibilisierung Allergo J 7 20 2
-
(1998)
Allergo J
, vol.7
, pp. 20-2
-
-
Sennekamp, J.1
Walter, S.2
-
18
-
-
0029265960
-
Immunotherapy compliance - A shot in the dark?
-
S.R. Wynn 1995 Immunotherapy compliance - a shot in the dark? Ann AllergyAsthma Immunol 74 195 7
-
(1995)
Ann Allergy Asthma Immunol
, vol.74
, pp. 195-7
-
-
Wynn, S.R.1
|